Hydrochloric Acid → Hydrochloric Acid
Reaction equation
[F:1][C:2]([F:23])([F:22])[O:3][C:4]1[CH:9]=[CH:8][C:7]([C:10]2[CH:11]=[CH:12][C:13]3[O:19][CH2:18][CH2:17][NH:16][C:15](=O)[C:14]=3[CH:21]=2)=[CH:6][CH:5]=1.CO.[ClH:26]>C1COCC1.B>[F:23][C:2]([F:1])([F:22])[O:3][C:4]1[CH:9]=[CH:8][C:7]([C:10]2[CH:11]=[CH:12][C:13]3[O:19][CH2:18][CH2:17][NH:16][CH2:15][C:14]=3[CH:21]=2)=[CH:6][CH:5]=1.[ClH:26]Participants
Reactant 3
Product 2
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 70 °C
Procedure
To a solution of 7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one (660 mgs, 2.0 mmol) in THF (6 mL), 1.0M Borane in THF (6.0 mL, 6.0 mmol) was added and the mixture was heated at 70° C. After 16 h, the mixture was cooled to rt and Methanol (22 mL) and 6.0M HCl (22 mL) was added and stirred at rt for 2 h. The reaction mixture was then concentrated and the solids formed were filtered and washed with ether and dried to give 7-(4-(trifluoromethoxy)phenyl)-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine as HCl salt. The above compound (100 mgs, 0.29 mmol), pyrimidine-2-carboxylic acid (47 mgs, 0.38 mmol), HATU (143 mgs, 0.38 mmol), in DMF (1 mL) was added NMM (0.1 mL, 0.86 mmol) and stirred at 60° C. for 30 min. The reaction mixture was then diluted with EtOAc and washed with NaHCO3, brine and dried (MgS(O)4). The mixture was the filtered, concentrated and chromatographed (SiO2, 50% EtOAc/DCM) to provide the title compound.
Workup
- temperaturethe mixture was cooled to rt
- concentrationThe reaction mixture was then concentrated
- customthe solids formed
- filtrationwere filtered
- washwashed with ether
- customdried
Sources & evidence
- ORD record
- ord-f1086e06719042d7a17316e1244d0eda
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08697863B2
Reaction notes
Loading…